Synlett · 1993 · 19 citations · 0 references
PharmacyChemistryMedicinal ChemistryDrug DesignDrug DiscoverySynthetic Medicinal ChemistryHigh-throughput SynthesisPeptide ChemistryChemical Synthesis Of AnaloguesMulti-step SynthesisPeptide Medicinal ChemistryRenin-angiotensin System InhibitorsRenin-angiotensin-aldosterone System Inhibitors
An economical asymmetric four step synthesis of a 2(R)-benzylsuccinic acid-4-monoamide for use as an N-terminal component in renin inhibitors has been developed (Scheme 3).